Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial
Guy Thwaites(Oxford University Clinical Research Unit), A. Sarah Walker(Health Protection Scotland), Tim Planche(Leeds Teaching Hospitals NHS Trust), Sarah Wyllie(Portsmouth Hospitals NHS Trust), Neil Jenkins(Heart of England NHS Foundation Trust), Julia Greig(Sheffield Teaching Hospitals NHS Foundation Trust), M. Estée Török(National Health Service), Susan Hopkins(National Security Agency), Robert Tilley(National Health Service), Dakshika Jeyaratnam(St George’s University Hospitals NHS Foundation Trust), Richard Cunningham(Plymouth Hospital), Marta Soares(University of York), Martin Llewelyn(Brighton and Sussex Medical School), Matthew Scarborough(MACOM (United States)), Cressida Auckland(Royal Devon & Exeter NHS Foundation Trust), Jonathan D. Edgeworth(King's College London), Sarah Meisner(MRC Unit the Gambia), Gavin Barlow(University of Liverpool), Robert C. Read(University Hospital Southampton NHS Foundation Trust), Peter Wilson(National Health Service), John Williams(University of Cambridge), Emmanuel Nsutebu(Cardiff University)
Cited by 27
Related Papers
Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis
|The Lancet Infectious Diseases|2018|3k
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
|Nature|2021|1.3k
ESCMID guideline: diagnosis and treatment of acute bacterial meningitis
|Clinical Microbiology and Infection|2016|899